Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
2321
-
2322
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2323
-
2324
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2325
-
2326
-
2327
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2328
-
2329
-
2330
-
2331
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2332
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2333
-
2334
-
2335
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2336
-
2337
-
2338
-
2339
-
2340